Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Regulation and Compliance > Federal Regulation

FDA panel urges looser restrictions on diabetes drug Avandia

X
Your article was successfully shared with the contacts you provided.

Despite lingering concerns about increased susceptibility to heart problems when taking Avandia, a Type 2 diabetes medication, the majority of a Federal Drug Administration advisory panel suggested that the drug have looser restrictions. It will now be up to FDA Commissioner Margaret Hamburg to make a decision.